Literature DB >> 10822942

Secular trends of HBeAg prevalence among HBsAg-positive delivery mothers in a hepatitis B endemic area.

S N Lu1, J H Liu, J H Wang, C C Lu.   

Abstract

A high prevalence of HBeAg among HBsAg-positive mothers at the time of delivery results in a high prevalence of hepatitis B vertical transmission. From 1990 to 1995, 896 pregnant HBsAg-positive women, including 411 (46 per cent) HBeAg-positive subjects, were enrolled in our study to analyse the secular change in HBeAg prevalence. Their mean age, number of pregnancies and parity were 29.5 +/- 4.1 years, 2.0 +/- 1.2, and 0.6 +/- 0.7, respectively. The prevalence rates of HBeAg were 48, 54, 49, 47, 40, and 40 per cent among the subjects enrolled in 1990, 1991, 1992, 1993, 1994, and 1995, respectively. In univariate analyses, prevalence of HBeAg decreased by the calendar year of pregnancy (p = 0.01), and also by age (p < 0.00001), number of pregnancies (p < 0.0001) and parity (p < 0.0002). After adjusting for age in multiple logistic regression, the calendar year of pregnancy was still the independent variable, while gravida and parity became insignificant. The odd ratios (95 per cent confidence interval) of HBeAg negative-seroconversion in the equations were 1.09 (1.00-1.19) per calendar year and 1.14 (1.10-1.18) per year of age. Our results have shown a secular decrease in HBeAg-prevalence among pregnant HBsAg-positive women in Taiwan.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10822942     DOI: 10.1093/tropej/46.2.121

Source DB:  PubMed          Journal:  J Trop Pediatr        ISSN: 0142-6338            Impact factor:   1.165


  5 in total

1.  Age, race and viral genotype are associated with the prevalence of hepatitis B e antigen in children and adults with chronic hepatitis B.

Authors:  Adrian M Di Bisceglie; Wendy C King; Mauricio Lisker-Melman; Mandana Khalili; Steven H Belle; Jordan J Feld; Marc G Ghany; Harry L A Janssen; Daryl Lau; William M Lee; Simon C Ling; Stewart Cooper; Philip Rosenthal; Kathleen B Schwarz; Richard K Sterling; Jeffrey H Teckman; Norah Terrault
Journal:  J Viral Hepat       Date:  2019-05-02       Impact factor: 3.728

2.  Association of Nationwide Hepatitis B Vaccination and Antiviral Therapy Programs With End-Stage Liver Disease Burden in Taiwan.

Authors:  Chun-Ju Chiang; Jing-Rong Jhuang; Ya-Wen Yang; Bo-Zhi Zhuang; San-Lin You; Wen-Chung Lee; Chien-Jen Chen
Journal:  JAMA Netw Open       Date:  2022-07-01

3.  Seroepidemiology of HBV infection in South Korea, 1995 through 1999.

Authors:  M K Jang; J Y Lee; J H Lee; Y B Kim; H Y Kim; M S Lee; C K Park; J Y Yoo
Journal:  Korean J Intern Med       Date:  2001-09       Impact factor: 2.884

4.  Changes in the Prevalence of HBsAg and HBeAg: a Study of 8696 Parturients in a Well Vaccinated Area.

Authors:  Chen-Hsuan Wu; Te-Yao Hsu; Fu-Tsai Kung; Chan-Chao ChangChien; Ching-Chang Tsai; Sheng-Nan Lu
Journal:  Sci Rep       Date:  2017-04-27       Impact factor: 4.379

5.  Effects of sex and generation on hepatitis B viral load in families with hepatocellular carcinoma.

Authors:  Ai-Ru Hsieh; Cathy Sj Fann; Chau-Ting Yeh; Hung-Chun Lin; Shy-Yi Wan; Yi-Cheng Chen; Chia-Lin Hsu; Jennifer Tai; Shi-Ming Lin; Dar-In Tai
Journal:  World J Gastroenterol       Date:  2017-02-07       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.